Penumbra
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Penumbra and other ETFs, options, and stocks.About PEN
Penumbra, Inc. is a thrombectomy company, which designs, develops, manufactures, and markets innovative medical products. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device system.
PEN Key Statistics
Stock Snapshot
With a market cap of 10.97B, Penumbra(PEN) trades at $280.07. The stock has a price-to-earnings ratio of 66.93.
During the trading day, Penumbra(PEN) stock saw an opening price of $277.95, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 572.61K.
The stock's 52-week range extends from a low of $221.26 to a high of $310.00.
The stock's 52-week range extends from a low of $221.26 to a high of $310.00.
PEN News
Penumbra (PEN) has caught investors’ attention lately, with shares up about 11% over the past month and 18% for the past year. The company’s consistent gains re...
Penumbra, Inc. recently reported third quarter results with sales reaching US$354.69 million and net income rising to US$45.85 million, alongside raising its 20...
Penumbra, Inc. PEN reported third-quarter 2025 adjusted earnings per share (EPS) of 97 cents, which surpassed the Zacks Consensus Estimate by 7.78%. Adjusted EP...
